Stem Cell Sciences receives DTI funding
Tuesday, 01 February, 2005
A consortium led by Stem Cell Sciences' UK centre has been awarded £1.2 million by the UK Department of Trade and Industry (DTI) to fund a program in drug discovery for regenerative medicine.
The consortium, which comprises Stem Cell Sciences, the Institute for Stem Cell Research at the University of Edinburgh, University College London Biochemical Engineering, GE Biosciences, Global Research Centre and the Insight Faraday Partnership, plans to develop high throughput cell screening using high density arrays of specific cell types derived from embryonic stem cells, which will be used to speed the discovery of drug based regenerative medicines.
The grant was one of three awarded to consortia of academic and industry groups in the bioprocessing sector, a key business area for funding under the DTI's Technology Programme, which aims to speed the translation of collaborative research into successful businesses.
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
